Sang Hyun Lee

Sang Hyun Lee has extensive work experience in the biopharmaceutical industry. Sang Hyun is currently the VP of Biology at Prelude Therapeutics, where they started in September 2022. Before joining Prelude Therapeutics, Sang Hyun Lee worked at Arvinas as a Senior Director from December 2018 to September 2022. Prior to that, they were an Associate Director at Incyte from April 2011 to November 2018. Sang Hyun Lee began their career at Dana-Farber Cancer Institute in September 2000, where they held the roles of Research Fellow and Research Scientist until April 2011.

Sang Hyun Lee earned a Ph.D. in Molecular and Cell Biology from the University of Texas at Dallas, completing their studies from 1994 to 2000.